Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

MHRA

- PMLiVE

UCB strikes new Middle East and African sales deal for key products

Drops the RX Group to partner with NewBridge Pharmaceuticals

- PMLiVE

UK considers greater self-regulation of pharmacies

And MHRA to review sanctions and penalties

- PMLiVE

UCB’s chair Gerhard Mayr joins Almirall board

He becomes an independent director of the Spanish pharma company

- PMLiVE

Amgen’s Anna Richo joins UCB as executive VP and general counsel

Meanwhile, Cynthia Patton takes over as Amgen’s senior VP and chief compliance officer

- PMLiVE

MHRA appoints Michael Rhodes as medical director of devices

He will take over from Dr Susanne Ludgate, who is retiring in December

- PMLiVE

Massive crackdown on online pharmacies nets fake drugs

Global agencies shut down 18,000 websites and seize medicines worth $10.5m

- PMLiVE

UCB opens biotech plant in Belgium

100 jobs created as pharma firm plans to expand its focus on biologics

- PMLiVE

Hanover wins UCB pitch

The agency aims to raise the profile of the biopharma company

- PMLiVE

MHRA’s Dr June Raine to chair new EMA pharmacovigilance committee

Pharmacovigilance Risk Assessment Committee (PRAC) will lead implementation of reforms

Gordon Duff to chair UK’s MHRA

Three non-executive directors also join UK’s medicines regulator

- PMLiVE

Interview with Roch Doliveux, UCB

Why is patient-centricity placed at the heart of UCB? Jacky Law asked UCB’s CEO to explain his company’s philosophy

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links